Baxter continues to push the boundaries of what’s possible in renal care. We are committed to advancing dialysis and hemodialysis treatment in ground-breaking and meaningful ways to give more choices to patients.


 ESRD patients in the US


of incident patients are treated by In-Center Hemodialysis1 


is the annual growth of prevalent ESRD cases in the U.S.1

Therapy Options

At Baxter, we don’t believe in delivering the same standardized therapy to all patients, but instead provide choices to select the therapy and treatment modality that is right for both patients and clinics.

User interacting with the AK98 screen

Baxter's next-generation hemodialysis machine

Since first introduced in 1967, the Artificial Kidney Family has demonstrated a proven track record in dialysis care and significantly improved the field through groundbreaking technology and first-to-market advancements. The AK 98 continues this tradition and legacy.